期刊文献+

心水通胶囊水提物对缺氧损伤性人主动脉内皮细胞LDH、MDA和SOD的影响 被引量:6

Effects of Water Extracts of Xinshuitong Capsule on LDH,MDA and SOD in the Human Aortic Endothelial Cells Induced by Hypoxia
下载PDF
导出
摘要 目的:研究心水通胶囊水提物的细胞毒理学作用。方法:水煎煮法提取心水通胶囊中水溶性成分,不同浓度干预缺氧诱导的人主动脉内皮细胞,并与相同浓度梯度呋塞米组对照。采用MTF比色法、酶学方法以及病理形态学等方法,分别检测细胞活性、培养液中LDH、MDA和SOD含量以及细胞病理形态变化。结果:在0.5-1.5mg/mL浓度之间,心水通胶囊组比缺氧模型组细胞存活率增明显增高(P〈0.05)。在该浓度区间,细胞培养液中LDH和MDA活力降低,而SOD的活力增强,且该作用呈药物浓度依赖性;心水通胶囊组细胞形态正常,贴壁生长良好,未见明显细胞毒性作用。呋塞米组LDH和MDA活力随浓度而增高,而SOD活力和细胞活率降低,细胞毒性也增加。结论:心水通胶囊对缺氧诱导的细胞损伤具有一定保护作用,细胞毒性小。 Objective:To study the water extracts of Xinshuitong Capsule' s toxicity on human aortic endothelial cells. Methods : Use water decoction methods to extract the capsule' s water - soluble components. Oxygen - starved cells were treated with different concentrations of the extracts, and parellel experiments were performed with furosemide. MTI', en- zymology and pathological morphology were applied to test the activity of cells, LDH, MDA and SOD in the medium, and cell pathological changes, respectively. Results : Between 0.5 ~ 1.5 mg/mL, the extracts treating cells showed a dose - dependent and significant increase in cell activity compared with those in the hypoxia model group ( P 〈 0.05 ). Meanwhile, LDH and MDA reduced, but SOD increased in the cell medium, and this effect was also related to the con- centration dependence. The extracts treating cells showed normal in shape and good growth, without clear cell toxic effect in variable concentrations. In Furosemide group we found the increase in LDH and MDA, but decrease in SOD, and the cell toxicity also exacerbated in a dose - dependent manner, Conclusion : Xinshuitong capsule shows a protective effect on hypoxia- induced cells with little cell toxicity.
出处 《中医药学报》 CAS 2013年第6期47-50,共4页 Acta Chinese Medicine and Pharmacology
基金 福建省卫生厅医学创新课题(No.2011-CX-27) 福建省自然科学基金(No.2013J01334)
关键词 心水通胶囊 缺氧性损伤 人主动脉内皮细胞 细胞毒理学 Xinshuitong capsule Hypoxic damage Human aortic endothelial cells Cell toxicity
  • 相关文献

参考文献6

二级参考文献13

  • 1王玉堂.ESC急性心力衰竭诊断及治疗指南解读[J].心血管病学进展,2006,27(2):139-144. 被引量:18
  • 2陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:919. 被引量:692
  • 3De Bruyne L K M. Mechanisms and management of diuretic resistance in congestive heart failure [ J ]. Postgrad Med J, 2003, 79:268 - 271. 被引量:1
  • 4Ellison DH. Diuretic resistance: physiology and therapeutics [J]. Semin Nephrol, 1999, 19:581-597. 被引量:1
  • 5Hall D Controversies in heart faiture.Are beneficial effects of angiotensin—converting enzyme inhibitors attenuated by aspirin in patients with heart failure.Cardiol Clin.2001,19:587~603. 被引量:1
  • 6Ellison DH Diuretic resistance:physiology and therapeutics.Semin Nephrot.1 999,19:581~597. 被引量:1
  • 7Neuberg GW.Millet AB.O’Connor CM.et al.Diuretic resistace predicts mortality in patients with advanced heart failure.Am Heart J.2002,144:31~38. 被引量:1
  • 8Minutolo R.Andreucci M.Balletta MM.et al.Effect of posture on sodium excretion and diuretic effcacy in nephritic patients.Am J Kidney Dis.2000,34:719~727. 被引量:1
  • 9Taylor SH.Diuretic therapy in congestive heart failure.Cardiol Rev.2000,8:104~114. 被引量:1
  • 10Kramer BK.Schweda F.Riegger GA.Diuretic treatment and diuretic resistance in heart failure.Am J Med.1999,106:90~96. 被引量:1

共引文献31

同被引文献87

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部